Intrinsic Value of S&P & Nasdaq Contact Us

Lantheus Holdings, Inc. LNTH NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
83/100
7/7 Pass
SharesGrow Intrinsic Value
$158.94
+92.1%
Analyst Price Target
$87.00
+5.1%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Lantheus Holdings, Inc. (LNTH) trades at a trailing P/E of 22.5, forward P/E of 15.9. Trailing earnings yield is 4.44%, forward earnings yield 6.27%. PEG 0.31 (Peter Lynch undervalued ≤1.0). Graham Number is $36.49.

Criteria proven by this page:

  • VALUE (78/100, Pass) — P/E is below market average (22.5); PEG ≤ 1.0 — Peter Lynch undervalued (0.31); earnings yield beats bond yields (4.44%).
  • Forward P/E 15.9 (down from trailing 22.5) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.31 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 4.44% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 6.27% as earnings recover.
  • Analyst consensus target $87.00 (+5.1% upside) — modest upside expected.

Overall SharesGrow Score: 83/100 with 7/7 criteria passed.

SharesGrow 7-Criteria Score
83/100
SG Score
View full scorecard →
VALUE
78/100
Price-to-Earnings & upside
Proven by this page
FUTURE
73/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
HEALTH
100/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
90/100
→ Income
INCOME
70/100
→ Income

Valuation Snapshot — LNTH

Valuation Multiples
P/E (TTM)22.5
Forward P/E15.9
PEG Ratio0.31
Forward PEG0.31
P/B Ratio4.82
P/S Ratio3.38
EV/EBITDA13.7
Per Share Data
EPS (TTM)$3.56
Forward EPS (Est.)$5.19
Book Value / Share$16.62
Revenue / Share$23.51
FCF / Share$5.32
Yields & Fair Value
Earnings Yield4.44%
Forward Earnings Yield6.27%
Dividend Yield0.00%
Graham Number$36.49
SharesGrow IV$158.94 (+92.1%)
Analyst Target$87.00 (+5.1%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 10.3 -0.04 -2.59 0.91 -
2017 6.2 0.02 32.73 2.30 -
2018 14.8 -0.22 8.43 1.74 -
2019 25.3 -1.07 6.98 2.30 -
2020 -54.2 0.41 1.42 2.15 -
2021 -27.4 -0.08 4.20 4.59 -
2022 124.3 -0.90 7.81 3.73 -
2023 13.0 0.01 5.19 3.26 -
2024 19.8 -3.52 5.69 4.04 -
2025 19.2 -0.82 4.12 2.91 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.82 $301.85M $26.76M 8.9%
2017 $3.17 $331.38M $123.39M 37.2%
2018 $1.03 $343.37M $40.52M 11.8%
2019 $0.79 $347.34M $31.67M 9.1%
2020 $-0.25 $339.41M $-13.47M -4%
2021 $-1.06 $425.21M $-71.28M -16.8%
2022 $0.40 $935.06M $28.07M 3%
2023 $4.65 $1.3B $326.66M 25.2%
2024 $4.36 $1.53B $312.44M 20.4%
2025 $3.41 $1.54B $233.56M 15.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $5.19 $5.00 – $5.63 $1.45B $1.41B – $1.57B 8
2027 $6.29 $5.96 – $6.76 $1.65B $1.54B – $1.84B 8
2028 $7.63 $5.63 – $10.41 $1.88B $1.88B – $1.89B 3
2029 $7.62 $7.20 – $8.67 $1.99B $1.91B – $2.2B 1
2030 $8.44 $7.97 – $9.60 $2.19B $2.1B – $2.42B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message